InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 02/19/2023

Re: None

Tuesday, 01/23/2024 10:00:37 PM

Tuesday, January 23, 2024 10:00:37 PM

Post# of 705252
Where are we in the NICE guidance process "To appraise the clinical and cost effectiveness of DCVax-L for newly diagnosed glioblastoma multiforme."
The most recent entry in the Timeline is dated Dec. 23, 2022. https://www.nice.org.uk/guidance/indevelopment/gid-ta10143

I thought the process would have started concurrent to the MAA submission.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News